We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Mendel Biotechnology Stock

Invest in or calculate the value of your shares in Mendel Biotechnology or other pre-IPO companies through EquityZen's platform.

Get Started

Mendel Biotechnology Stock

Mendel Biotechnology is a plant biotechnology company that develops genetic and chemical solutions for a range of agricultural markets.

About Mendel Biotechnology Stock

Founded

1997

Headquarters

Hayward, CA, US

Total Funding

20.2M

Industries

Software, Artificial Intelligence, Data and Analytics

Mendel Biotechnology, Inc. operates as a plant biotechnology company. The company focuses on developing genetic and chemical solutions for a range of agricultural markets. It offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company has strategic partnerships with Monsanto Corporation, BP, and Bayer CropScience. Mendel Biotechnology, Inc. was founded in 1997 and is based in Hayward, California. It has operations in the United States, Europe, and China.

Mendel Biotechnology Management

Leadership team at Mendel Biotechnology

Sr. Vice President, Corporate Development

Greg Ikonen

Sr. Vice President, Research

Oliver J. Ratckliffe

Locked Features

Join now and verify your accreditation status to gain access to:

  • Mendel Biotechnology current valuation
  • Mendel Biotechnology stock price
  • Available deals in Mendel Biotechnology and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Mendel Biotechnology stock?

Accredited investors can buy pre-IPO stock in companies like Mendel Biotechnology through EquityZen funds. These investments are made available by existing Mendel Biotechnology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Mendel Biotechnology stock?

Shareholders can sell their Mendel Biotechnology stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."